Federal Agency · National Institutes of Health
Metastasis Research Network (U54 Clinical Trial Not Allowed)
Last updated: September 26, 2026
Posted June 4, 2026
Funding
Up to $1.3M
Closes
September 25, 2026
NAICS
541714
Similar grants still open
- FY2026 Implementation of the Quagga and Zebra Mussel Action Plan (QZAP) in the Western United StatesFish and Wildlife Service · closes October 24, 2026
- Assisting Specialty Crop Exports: Low Oxygen Storage and Packaging Systems for U.S. Tree Nuts with Phytosanitary TraceabilityForeign Agricultural Service · closes October 26, 2026
- Climate Program Office (CPO) FY2026 Earth System Science and Services PartnershipDOC NOAA - ERA Production · closes October 26, 2026
- Long-term health outcomes of people living with spina bifidaCenters for Disease Control - NCBDDD · closes October 26, 2026
- ROSES25: D.8 Habitable Worlds Observatory Precursor Science InvestigationNASA Headquarters · closes October 26, 2026
- Strengthening Bosnia and Herzegovina’s Organized Crime Specialized Departments for Organized Crime Through Expert Advisory SupportU.S. Mission to Bosnia and Herzegovina · closes October 27, 2026
- OJP FY 2026 Special Attorneys Program Round 10Bureau of Justice Assistance · closes October 28, 2026
- NASA Innovative Advanced Concepts (NIAC) Phase INASA Headquarters · closes October 28, 2026
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on developing a comprehensive and cohesive understanding of cancer metastasis. Towards this goal, the NCI will support U54 Specialized Centers that together will continue to serve as the hub of the Metastasis Research Network (MetNet). Each MetNet Center should propose an overarching scientific theme that will be pursued through two or three scientific inter- and multidisciplinary basic research projects. The projects should use integrative system level approaches to elucidate and integrate a mechanistic understanding of the non-linear, dynamic, and emergent processes in metastasis. Overarching themes should encompass the interplay between at least two central elements in the metastatic process such as early dissemination, cellular, soluble and/or physical microenvironment crosstalk, dormancy, or mechanisms of responses by metastatic cells to therapies. Studies on all types of cancer are welcome, including rare and pediatric metastatic cancers.Research proposed by MetNet Centers is expected to advance our understanding towards a more comprehensive appreciation of metastasis as a whole body, systems-level problem.
Eligibility
- Funded by NIH
Award details
Award range: Up to $1.3M. Applications close on September 25, 2026.
Categories
Not categorized
This grant is no longer accepting applications. Get matched to open grants like it, or browse the ones above.
See similar open grants ↑Applications closed — listing kept for reference.·Source: Grants.gov·Last seen Sep 25, 2026